Search results
Results From The WOW.Com Content Network
This condition may follow certain diseases such as syphilis, or can result from fever, trauma, systemic upsets or adverse reaction to drugs. Onychorrhexis also known as brittle nails, is brittleness with breakage of fingernails or toenails. Paronychia is a bacterial or fungal infection where the nail and skin meet.
After topical antibiotic treatment, the discolored nail section is receding Oral antibiotics are rarely necessary, helpful [ 4 ] or recommended by all practitioners. [ 3 ] Moderate cases of green nail syndrome may be prescribed topical antibiotics ( silver sulfadiazine , gentamicin , ciprofloxacin , bacitracin and polymyxin B ). [ 16 ]
Onychorrhexis (from the Greek words ὄνυχο- ónycho-, "nail" and ῥῆξις rhexis, "bursting"), is a brittleness with breakage of finger or toenails that may result from hypothyroidism, anemia, anorexia nervosa or bulimia, or after oral retinoid therapy. [1]: 786 It can also be seen in melanoma that involves the nail and onychomycosis. [2]
Neomycin/polymyxin B/bacitracin, also known as triple antibiotic ointment, is an antibiotic medication used to reduce the risk of infections following minor skin injuries. [ 1 ] [ 2 ] It contains the three antibiotics neomycin , polymyxin B , and bacitracin . [ 1 ]
Acute paronychia is usually caused by bacteria. It is often treated with antibiotics, either topical (applied to the skin) or oral (taken by mouth), or both.Chronic paronychia is most often caused by a yeast infection of the soft tissues around the nail but can also be traced to a bacterial infection.
However, these classifications are based on laboratory behavior. The development of antibiotics has had a profound effect on the health of people for many years. Also, both people and animals have used antibiotics to treat infections and diseases. In practice, both treat bacterial infections. [1]
A bacterial infection, treatable with antibiotics. One study compared patients with ingrown toenails to healthy controls and found no difference in the shape of toenails between those of patients and of the control group. The study suggested that treatment should not be based on the correction of a non-existent nail deformity.
Efinaconazole, sold under the brand name Jublia among others, is a triazole antifungal medication. It is approved for use in the United States, Canada, and Japan as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). [3] [4] Efinaconazole acts as a 14α-demethylase inhibitor. [5] [2]